PDB 6o3i

PDB Information

PDB6O3I
MethodX-RAY DIFFRACTION
Host OrganismEscherichia coli
Gene SourceHomo sapiens
Primary Citation
Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1.
Kumar, S., Waldo, J.P., Jaipuri, F.A., Marcinowicz, A., Van Allen, C., Adams, J., Kesharwani, T., Zhang, X., Metz, R., Oh, A.J., Harris, S.F., Mautino, M.R.
J.Med.Chem.
HeaderOxidoreductase/Inhibitor
Released2019-02-26
Resolution2.690
CATH Insert Date04 Aug, 2019

PDB Images (3)

PDB Prints

PDB Chains (2)

Chain ID Date inserted into CATH CATH Status
A 04 Aug, 2019 New
B 04 Aug, 2019 New

CATH Domains (0)

Domain ID Date inserted into CATH Superfamily CATH Status

UniProtKB Entries (0)

Accession Gene ID Taxon Description